Iskanje

The latest demographic data show that existing demographic tendencies, such as increasing median age, declining fertility rates and a shrinking working age population, continue to prevail. However, it is also becoming clear that the influence of the pandemic in 2021 was more significant than during the previous year – for instance, 'excess mortality' increased even further, while life expectancy decreased in many Member States. The pandemic also accelerated another phenomenon, present in our lives ...

In the midst of the current pandemic, adopting a gender perspective may seem a secondary concern. However, pandemics are known to affect women and men differently, making it essential to recognise these differences in order to understand the impacts on individuals and communities and to respond effectively and equitably. There is already clear evidence that the ongoing health, social and economic crisis is having gendered impacts. Disaggregated data show that sex and gender are playing a role in ...

A Workshop organised by the Policy Department C was held on the impact of economic crisis on access to healthcare and medicines. The speakers addressed issues such as budget cuts in health care, high price of medicines, inequalities in access to various treatments as a direct result of those cuts, addressed medicines as a financial products with their share on stock market which creates an artificial incentive to keep the high value for medicines, etc. Better coordinated procurement for medicines ...

This leaflet provides the main points on economic inequality and the take-home messages from the ECON/EMPL hearing on 21 June 2016 in an easy-to-read Q&A format, to make this topic more easily accessible to a wider audience. It has been prepared by the European Parliament’s Policy Department A on Economic and Scientific Policy.

Despite the UN pledge to reduce the maternal mortality ratio (MMR) by three-quarters by 2015, more than 350 000 maternal deaths occur every year, 99% of them in developing countries. Of all the Millennium Development Goals, least progress has been made on the one to improve maternal health. In the EU, the average MMR has been low and relatively steady in recent years. There are differences, however, between Member States (MS). Whereas, to some extent, they may be explained by unreliability of statistical ...

This publication is the result of a project commissioned by STOA under Framework Contract IP/A/STOA/FWC/2005-28 on "Future Development of Cancer Therapy". It contains contributions and discussions arising from a workshop that took place at the European Parliament in Brussels in February 2007 under the title "Gene, Vaccine and Immunotherapies against Cancer: New Approaches to an Old Problem".